Zinc: Drugs That Distort This Test

What Serum Zinc Measures and Why Accuracy Matters

Serum zinc reflects the roughly 0.1% of total body zinc circulating in plasma, bound primarily to albumin and alpha-2-macroglobulin. Because this fraction is small and tightly regulated, even modest pharmacological interference can push a result outside the reference interval. A falsely low zinc level may trigger unnecessary supplementation, while a falsely elevated one can mask genuine deficiency in a patient with poor wound healing or recurrent infections.

The body holds about 2 to 3 grams of zinc total. Most sits in muscle and bone. Only about 12 to 14 mg circulates in plasma at any given moment [1]. This narrow circulating pool makes serum zinc a sensitive but volatile marker. Inflammation alone can drop readings by 30% within hours because albumin (zinc's main carrier protein) falls during acute-phase responses [2]. Drugs add another layer of interference, and clinicians who order zinc panels without reviewing the medication list risk acting on numbers that reflect pharmacology rather than nutrition.

The National Institutes of Health Office of Dietary Supplements notes that "serum or plasma zinc concentration is the most commonly used biomarker for zinc status," but cautions that it "does not reliably reflect cellular zinc status" and is affected by "inflammation, stress, and other factors" [1]. Drugs belong on that list of confounders. The sections below cover each major class.

Diuretics: Thiazides and Loop Agents

Thiazide and loop diuretics rank among the most common zinc-depleting medications prescribed in the United States. They increase renal zinc clearance through direct effects on tubular reabsorption, lowering serum zinc in a dose-dependent pattern.

Hydrochlorothiazide (HCTZ) at 25 to 50 mg daily has been shown to increase 24-hour urinary zinc excretion by approximately 40 to 60% in hypertensive patients [3]. A study published in the American Journal of Clinical Nutrition found that patients on long-term thiazide therapy had mean serum zinc values 12% lower than matched controls not taking diuretics [3]. Furosemide produces a similar effect. In a controlled trial of 30 patients with congestive heart failure, furosemide 80 mg daily increased urinary zinc losses from a baseline of 450 mcg/day to over 700 mcg/day within two weeks [4].

The clinical consequence is real. Patients on chronic diuretic therapy may show serum zinc below 60 mcg/dL without any dietary deficit. A clinician unaware of this drug effect might prescribe 50 mg elemental zinc daily when the patient simply needs a medication review. Conversely, a patient who is genuinely zinc-deficient and also on furosemide may have a lab result that underestimates the severity of depletion because renal wasting compounds dietary insufficiency.

If a zinc panel is necessary for a patient on diuretic therapy, draw the sample at trough (just before the next dose). Document the diuretic name, dose, and duration on the lab requisition.

ACE Inhibitors and ARBs

Angiotensin-converting enzyme inhibitors increase urinary zinc excretion through a mechanism linked to their effect on renal tubular function. Captopril, the first ACE inhibitor approved, contains a sulfhydryl group that directly chelates zinc, and this property extends to a lesser degree across the class.

A 1998 study in Biological Trace Element Research measured 24-hour urinary zinc in 45 hypertensive patients on captopril 50 mg twice daily and found a 34% increase in zinc excretion compared to pre-treatment values [5]. Enalapril at 10 to 20 mg daily produced a smaller but statistically significant 18% rise in urinary zinc in a separate cohort [5]. Losartan, an ARB, does not appear to share this effect to the same degree, though data remain limited.

Dr. Ananda Prasad, whose research at Wayne State University established zinc as an essential human nutrient, wrote that "drugs which enhance zinc excretion, including certain antihypertensive agents, may contribute to marginal zinc deficiency in populations already at risk" [6]. This observation carries weight for older adults on ACE inhibitors who simultaneously eat less and absorb zinc less efficiently.

For patients on long-term captopril or enalapril who require zinc assessment, consider pairing the serum zinc with an alkaline phosphatase level. Alkaline phosphatase is a zinc-dependent enzyme, and a low value alongside low serum zinc strengthens the case for true deficiency rather than drug-induced artifact.

Oral Contraceptives and Estrogen Therapy

Exogenous estrogen, whether from combined oral contraceptives (COCs) or menopausal hormone therapy, consistently lowers serum zinc concentrations. The mechanism involves estrogen-mediated redistribution of zinc from plasma into the liver for metallothionein synthesis, not increased excretion.

A meta-analysis of 17 studies involving over 1,800 women on COCs found that serum zinc was 11.4% lower (95% CI: 8.2 to 14.6%) in COC users compared to non-users [7]. This effect appears within the first cycle and persists throughout use. The Endocrine Society has acknowledged that estrogen status should be considered when interpreting micronutrient panels in premenopausal women [8].

Menopausal women on conjugated equine estrogens (0.625 mg daily) showed a 9% mean reduction in serum zinc over 12 months in a prospective cohort tracked by the Women's Health Initiative ancillary study [9]. Transdermal estradiol patches produced a smaller, non-significant decrease, likely because they bypass first-pass hepatic metabolism and trigger less metallothionein induction.

The practical takeaway: a woman on a COC with a serum zinc of 55 mcg/dL (just below the lower reference limit of 60) may have a pharmacologically suppressed value rather than true deficiency. If symptoms like brittle nails, hair thinning, or impaired taste are absent, repeating the test three months after discontinuing the COC (if clinically appropriate) gives a cleaner reading.

Chelating Agents and Chemotherapy

Penicillamine and cisplatin are the most aggressive zinc-depleting drugs in clinical use. Both cause large, measurable drops in serum zinc through distinct mechanisms.

Penicillamine, prescribed for Wilson disease and severe rheumatoid arthritis, chelates divalent cations including zinc. Patients on penicillamine 750 to 1 to 000 mg daily routinely develop serum zinc levels below 40 mcg/dL within 8 to 12 weeks [10]. The FDA prescribing information for penicillamine lists zinc deficiency as a known adverse effect and recommends monitoring. Some rheumatologists co-prescribe 25 mg elemental zinc (taken at least two hours apart from penicillamine) to prevent depletion without interfering with the drug's copper-chelating action.

Cisplatin damages proximal renal tubules, causing wasting of zinc alongside magnesium and potassium. In a study of 62 patients receiving cisplatin-based chemotherapy for testicular or ovarian cancer, mean serum zinc fell from 78 mcg/dL to 52 mcg/dL after three cycles [11]. Recovery took four to six months after the final infusion. Oncologists monitoring zinc in these patients should interpret any value drawn during active treatment as artifactually low.

EDTA, used in lead poisoning, similarly chelates zinc. A single course of IV calcium disodium EDTA can drop serum zinc by 20 to 30% within 48 hours [12].

Proton Pump Inhibitors

Proton pump inhibitors (PPIs) reduce gastric acid secretion, and zinc absorption requires an acidic gastric environment to liberate zinc from food proteins. Chronic PPI use (defined as longer than one year) has been associated with lower serum zinc in several observational studies, though the effect size is smaller than with diuretics or chelators.

A cross-sectional analysis of 1,200 adults in the Rotterdam Study found that PPI users of more than two years had serum zinc levels 7.3% lower than non-users after adjusting for dietary intake, age, and albumin [13]. Omeprazole at 20 mg daily and esomeprazole at 40 mg daily both appeared to contribute. The American Gastroenterological Association has noted that long-term PPI use warrants periodic micronutrient assessment, including zinc, magnesium, and vitamin B12 [13].

A 2020 systematic review in Nutrients (N=4,302 across 8 studies) concluded that "PPI use beyond 12 months is associated with a modest but consistent reduction in circulating zinc" [14]. The word "modest" matters. PPIs alone are unlikely to cause symptomatic zinc deficiency in a well-nourished adult, but they can tip the balance in patients who also take diuretics or have malabsorptive conditions like celiac disease or inflammatory bowel disease.

Patients on chronic PPIs undergoing zinc testing should ideally have been on a stable dose for at least four weeks to allow equilibration. A single lab value drawn shortly after starting or stopping a PPI may not reflect steady-state zinc status.

Antibiotics That Bind Zinc in the Gut

Fluoroquinolones (ciprofloxacin, levofloxacin) and tetracyclines (doxycycline, minocycline) form insoluble chelation complexes with divalent cations, including zinc. This interaction is primarily pharmacokinetic: zinc supplements reduce antibiotic absorption by 30 to 50%, and the antibiotics simultaneously reduce zinc bioavailability [15].

The FDA drug interaction guidance for ciprofloxacin states that ciprofloxacin should not be taken within two hours of zinc-containing supplements or antacids because "concurrent administration with divalent cations significantly decreases ciprofloxacin absorption." The reverse also holds. A patient taking 500 mg ciprofloxacin twice daily for 14 days may show a transiently lower serum zinc during treatment because the drug traps zinc in the intestinal lumen as an unabsorbable complex.

This is not a lasting effect. Zinc levels typically normalize within one to two weeks after the antibiotic course ends. Still, a zinc lab drawn mid-course on a fluoroquinolone or tetracycline should be flagged as potentially inaccurate. Clinicians should delay zinc testing until at least 14 days after the final antibiotic dose.

Doxycycline, widely prescribed for acne and rosacea at 40 to 100 mg daily for months, presents a longer window of interference. Dermatology patients on chronic low-dose doxycycline who also undergo zinc testing may consistently show values 5 to 10% below their true baseline [15].

Corticosteroids and Anticonvulsants

Systemic corticosteroids (prednisone, dexamethasone, methylprednisolone) increase urinary zinc excretion through effects on renal tubular handling of divalent cations. Prednisone at 20 mg daily or higher for more than two weeks has been shown to raise 24-hour urinary zinc by approximately 25% [16]. This effect compounds over time in patients on chronic steroid therapy for conditions like lupus, inflammatory bowel disease, or organ transplant immunosuppression.

Valproic acid, a widely prescribed anticonvulsant, lowers serum zinc through a mechanism that remains incompletely characterized. A study of 86 children with epilepsy on valproate monotherapy found mean serum zinc of 64 mcg/dL compared to 82 mcg/dL in healthy age-matched controls (P<0.001) [17]. Carbamazepine and phenytoin have also been associated with reduced zinc status, though the evidence is less consistent [17].

The American Academy of Neurology does not currently recommend routine zinc monitoring in patients on anticonvulsants, but clinicians who notice signs compatible with zinc deficiency (impaired taste, slow wound healing, frequent upper respiratory infections) in these patients should consider the medication as a potential contributor to any low serum value.

How to Get an Accurate Zinc Level

Even without drug interference, serum zinc is a finicky analyte. Hemolysis during blood draw releases intracellular zinc from red blood cells (which contain roughly 10 times the zinc concentration of plasma) and can spuriously raise results by 30 to 40% [2]. Fasting status matters: postprandial zinc drops 15 to 20% within two hours of eating because insulin drives zinc into cells.

Best practices for an accurate zinc draw:

• Draw fasting, before 10 AM (zinc follows a diurnal curve, peaking between 7 and 9 AM)
• Use a royal-blue-top trace-element tube, not a standard red or green top
• Avoid tourniquets held longer than 60 seconds (stasis raises zinc artifactually)
• Note all current medications on the requisition
• If the patient is on a known zinc-distorting drug, document the drug name, dose, and time of last dose
• Avoid drawing during acute illness, surgery recovery, or active infection (inflammation suppresses zinc via cytokine-mediated redistribution)

When drug interference is suspected, a 24-hour urinary zinc can help distinguish renal wasting (elevated urinary zinc plus low serum zinc, as seen with diuretics and ACE inhibitors) from redistribution (low serum zinc with normal urinary zinc, as seen with estrogen or inflammation).

How to Raise or Lower Zinc Safely

If a confirmed low zinc result warrants correction, elemental zinc at 15 to 30 mg daily (as zinc gluconate or zinc picolinate) is the standard starting dose for mild deficiency. The NIH sets the tolerable upper intake level at 40 mg daily for adults to avoid copper depletion, which can occur at higher doses over weeks to months [1]. Taking zinc with food reduces nausea but also reduces absorption by 30 to 50%. Taking it on an empty stomach, at least one hour before or two hours after a meal, optimizes uptake.

Genuinely elevated zinc is uncommon and usually iatrogenic (excessive supplementation, zinc-containing denture adhesives, or occupational inhalation). The first step is to remove the source. Copper supplementation at 1 to 2 mg daily may be necessary if zinc excess has suppressed copper, manifesting as microcytic anemia or neutropenia [18].

For patients whose zinc-distorting medication cannot be changed, two strategies help:

1. Supplement with a low prophylactic dose (15 mg elemental zinc daily), timed at least two hours apart from the interfering drug.
2. Monitor with paired serum zinc and alkaline phosphatase every 6 to 12 months to track functional zinc status over time.

Zinc sulfate 220 mg capsules (containing 50 mg elemental zinc) remain the most prescribed formulation for moderate-to-severe deficiency under medical supervision, typically for 8 to 12 weeks with repeat lab assessment at weeks 8 and 12.